ChemicalBook > CAS DataBase List > Varenicline-d4

Varenicline-d4

Product Name
Varenicline-d4
CAS No.
2183239-01-0
Chemical Name
Varenicline-d4
Synonyms
Varenicline-d4;D4-Varenicline;Varenicline Nitroso D4;7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline-7,7,9,9-d4
CBNumber
CB02675994
Molecular Formula
C13H13N3
Formula Weight
211.27
MOL File
2183239-01-0.mol
More
Less

Varenicline-d4 Property

storage temp. 
Store at -20°C
solubility 
Water: 0.0877 mg/mL
form 
A solid
Water Solubility 
Water: 0.0877 mg/mL
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
26102
Product name
Varenicline-d4
Purity
≥99% deuterated forms (d1-d4)
Packaging
500μg
Price
$93
Updated
2024/03/01
Cayman Chemical
Product number
26102
Product name
Varenicline-d4
Purity
≥99% deuterated forms (d1-d4)
Packaging
1mg
Price
$166
Updated
2024/03/01
AK Scientific
Product number
5896DV
Product name
13,13,15,15-Tetradeuterio-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
Packaging
1mg
Price
$282
Updated
2021/12/16
Medical Isotopes, Inc.
Product number
D37660
Product name
Varenicline-d4
Packaging
1mg
Price
$490
Updated
2021/12/16
More
Less

Varenicline-d4 Chemical Properties,Usage,Production

Description

Varenicline-d4 is intended for use as an internal standard for the quantification of varenicline by GC- or LC-MS. Varenicline is a full agonist of α7 subunit-containing neuronal nicotinic acetylcholine receptors (nAChRs; EC50 = 18 μM) and a partial agonist of α4β2 subunit-containing nAChRs (EC50 = 2.3 μM). Formulations containing varenicline have been used as aids in smoking cessation.

Uses

Varenicline-d4 is deuterium labeled Varenicline. Varenicline (CP 526555) is a potent partial agonist for α4β2 nicotinic acetylcholine receptor (nAChR) with an EC50 value of 2.3 μM. Varenicline is a full agonist for α3β4 and α7 nAChRs with EC50 values of 55 μM and 18 μM, respectively[1]. Varenicline is a nicotinic ligand based on the structure of cytisine, has the potential for smoking cessation treatment[2].

References

[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Mihalak KB, et al. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.Mol Pharmacol.?2006 Sep;70(3):801-5. Epub 2006 Jun 9. DOI:10.1124/mol.106.025130
[3] Bagdas D, et al. New insights on the effects of?varenicline?on nicotine reward, withdrawal and hyperalgesia in mice.Neuropharmacology.?2018 Aug;138:72-79. DOI:10.1016/j.neuropharm.2018.05.025

Varenicline-d4 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Varenicline-d4 Suppliers

BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81